A single elevated PSA level is not definitive for prostate cancer. Accurate diagnosis often requires follow-up with core needle biopsy and molecular tests like PHI, PCA3, or 4Kscore. These tools refine risk stratification and reduce unnecessary procedures, ensuring a more evidence-based diagnostic pathway.